surmount-1 tirzepatide obesity nejm 2022 weight loss percent 24.2%. That's the mean body reduction recorded in Retatrutide's Phase 2 trial — over 48 weeks, published in the New England Journal of Medicine. For context: that exceeded both semaglutide and Tirzepatide for the Treatment of

Never mix unit-based instructions with a milliliter syringe or vice versa

2013;21(3):E3227

Although ours is the first randomized controlled trial of a dual GIP and GLP-1 receptor agonist, prior studies have investigated the metabolic effects of selective GLP-1 RAs as an adjunct to insulin in type 1 diabetes

Do not follow a dosing chart from one pharmacy when using a vial from another

As established vendors exit the market, less scrupulous operators may fill the vacuum

Reading different syringe sizes On a 0.3 mL syringe with half-unit markings, each long line represents 1 unit and each short line represents 0.5 units